|
US2737518A
(en)
*
|
1955-01-19 |
1956-03-06 |
Schering Corp |
1-hydroxycortisone, 1-hydroxyhydrocortisone and esters thereof
|
|
US2968655A
(en)
*
|
1956-11-23 |
1961-01-17 |
Upjohn Co |
11-oxygenated-6-methyl progesterone and intermediates therefor
|
|
US2920999A
(en)
|
1957-06-07 |
1960-01-12 |
Pfizer & Co C |
21-nitrogen derivatives of corticosteroids
|
|
DE1165595B
(de)
|
1958-03-04 |
1964-03-19 |
Olin Mathieson |
Verfahren zur Herstellung von Triamcinolonacetonid-21-hemisuccinat und dessen Salzen
|
|
GB889766A
(en)
|
1958-03-04 |
1962-02-21 |
Olin Mathieson |
Improvements in steroids and the synthesis thereof
|
|
US3197469A
(en)
|
1958-08-06 |
1965-07-27 |
Pharmaceutical Res Products In |
16, 17-acetals and ketals of 6-halo-16, 17-dihydroxy steroids of the pregnane seriesand intermediates therefor
|
|
US3007923A
(en)
*
|
1959-01-22 |
1961-11-07 |
Lab Francais Chimiotherapie |
Process for the fluorination of 9beta, 11beta-epoxy and 5alpha, 6alpha-epoxy steroids
|
|
GB898295A
(en)
|
1959-03-18 |
1962-06-06 |
Upjohn Co |
Improvements in or relating to steroids and the manufacture thereof
|
|
US3033874A
(en)
|
1960-05-11 |
1962-05-08 |
Pfizer & Co C |
17beta-propenoyl steroids and process for preparing same
|
|
US3033873A
(en)
|
1960-05-11 |
1962-05-08 |
Pfizer & Co C |
21-aminomethyl-pregnenes
|
|
US3020275A
(en)
*
|
1960-06-07 |
1962-02-06 |
American Cyanamid Co |
21-nitrogen substituted steroids of the pregnane series and methods of preparing the same
|
|
DE1169444B
(de)
*
|
1961-02-22 |
1964-05-06 |
Schering Ag |
Verfahren zur Herstellung von ?-16ª-Methylsteroiden
|
|
US3047468A
(en)
*
|
1961-06-06 |
1962-07-31 |
American Cyanamid Co |
Method of preparing delta1, 4-3-keto steroids of the pregnane series
|
|
US3383394A
(en)
*
|
1965-08-30 |
1968-05-14 |
Schering Corp |
Novel 17-acylating process and products thereof
|
|
US3798216A
(en)
|
1969-03-07 |
1974-03-19 |
Fabrication Des Antibiotique S |
9-fluoro-11beta,21-dihydroxy-16alpha,17-(2-propenylidenedioxy)-pregna-1,4-diene-3,20-dione and derivatives thereof
|
|
DE2047105C3
(de)
|
1970-09-18 |
1979-02-15 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
17-Chlorsteroide und Verfahren zu ihrer Herstellung
|
|
IT1057859B
(it)
|
1972-04-28 |
1982-03-30 |
Sigma Tao Ind Farmaceutiche Sp |
Perivato del triamoinolone
|
|
SE378109B
(enExample)
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
|
SE378110B
(enExample)
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
|
US4076737A
(en)
|
1975-02-20 |
1978-02-28 |
Ciba-Geigy Corporation |
Aldehydes of the pregnane series and derivatives thereof
|
|
IL73337A
(en)
|
1984-10-28 |
1988-09-30 |
Yissum Res Dev Co |
Antitumor steroid-platinum complexes and method for the preparation thereof
|
|
ES8605537A1
(es)
|
1985-07-03 |
1986-02-01 |
Elmu Sa |
Procedimiento de obtencion de cetales ciclicos de corticoi- des y sus 21-c esteres
|
|
SE8604059D0
(sv)
|
1986-09-25 |
1986-09-25 |
Astra Pharma Prod |
A method of controlling the epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives
|
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5116829A
(en)
*
|
1990-04-23 |
1992-05-26 |
Kao Corporation |
Steroid compounds
|
|
US5183815A
(en)
|
1991-01-22 |
1993-02-02 |
Merck & Co., Inc. |
Bone acting agents
|
|
AU675916B2
(en)
|
1991-06-14 |
1997-02-27 |
Genentech Inc. |
Method for making humanized antibodies
|
|
CZ171095A3
(en)
|
1993-01-08 |
1996-01-17 |
Astra Ab |
Novel steroidal derivatives specific for colon or ilium
|
|
DE4311987A1
(de)
|
1993-04-07 |
1994-10-13 |
Schering Ag |
Neue Glucocorticoide
|
|
US5714586A
(en)
|
1995-06-07 |
1998-02-03 |
American Cyanamid Company |
Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
|
|
US5824669A
(en)
|
1996-03-22 |
1998-10-20 |
Nitromed, Inc. |
Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
|
|
US5837698A
(en)
|
1996-05-02 |
1998-11-17 |
G. D. Searle & Co. |
Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
|
|
AU3703900A
(en)
|
1999-02-24 |
2000-09-14 |
Nitromed, Inc. |
Nitrosated and nitrosylated steroids for the treatment of cardiovascular diseases and disorders
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US20070258987A1
(en)
|
2000-11-28 |
2007-11-08 |
Seattle Genetics, Inc. |
Recombinant Anti-Cd30 Antibodies and Uses Thereof
|
|
SE0101220D0
(sv)
|
2001-04-04 |
2001-04-04 |
Astrazeneca Ab |
New use
|
|
US6908934B2
(en)
|
2001-06-11 |
2005-06-21 |
Merck & Co., Inc. |
Therapeutic compounds for treating dyslipidemic conditions
|
|
ITMI20020148A1
(it)
|
2002-01-29 |
2003-07-29 |
Nicox Sa |
Nuovi corticosteroidi
|
|
US20050009798A1
(en)
|
2002-02-20 |
2005-01-13 |
Sepracor Inc. |
Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
|
|
US7190468B2
(en)
|
2002-07-17 |
2007-03-13 |
Hewlett-Packard Development Company, L.P. |
Background document rendering system and method
|
|
DK1545613T3
(da)
|
2002-07-31 |
2011-11-14 |
Seattle Genetics Inc |
Auristatinkonjugater og deres anvendelse til behandling af cancer, en autoimmun sygdom eller en infektiøs sygdom
|
|
US7985422B2
(en)
*
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
|
EP1562627A4
(en)
|
2002-08-23 |
2006-11-02 |
Mclean Hospital Corp |
CORTICOSTEROID CONJUGATES AND ITS USES
|
|
CN104383554B
(zh)
|
2002-09-06 |
2018-06-08 |
天蓝制药公司 |
用于传递治疗剂的以环糊精为基础的聚合物
|
|
CN1414008A
(zh)
|
2002-10-17 |
2003-04-30 |
南开大学 |
含氮甾体化合物及其制备方法
|
|
US7015349B2
(en)
|
2003-03-26 |
2006-03-21 |
The Gillette Company |
Reduction of hair growth
|
|
PL2489364T3
(pl)
|
2003-11-06 |
2015-06-30 |
Seattle Genetics Inc |
Związki monometylowaliny zdolne do sprzęgania do przeciwciał
|
|
WO2005063777A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Corus Pharma |
Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation
|
|
US8101714B2
(en)
|
2004-02-18 |
2012-01-24 |
The University Of Georgia Research Foundation, Inc. |
Teleost derived antimicrobial polypeptides
|
|
US20050192257A1
(en)
|
2004-02-26 |
2005-09-01 |
Peyman Gholam A. |
Predictors for patients at risk for glaucoma from steroid therapy
|
|
AR048098A1
(es)
|
2004-03-15 |
2006-03-29 |
Wyeth Corp |
Conjugados de caliqueamicina
|
|
CN114053429A
(zh)
|
2004-06-01 |
2022-02-18 |
健泰科生物技术公司 |
抗体-药物偶联物和方法
|
|
EP1602931A1
(en)
|
2004-06-03 |
2005-12-07 |
Universiteit Leiden |
SR-A antagonists
|
|
US7541330B2
(en)
|
2004-06-15 |
2009-06-02 |
Kosan Biosciences Incorporated |
Conjugates with reduced adverse systemic effects
|
|
ATE411053T1
(de)
|
2004-08-09 |
2008-10-15 |
Deutsches Krebsforsch |
Albuminkonjugate, die eine glucuron-verknüpfung enthalten
|
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
|
EP1817341A2
(en)
|
2004-11-29 |
2007-08-15 |
Seattle Genetics, Inc. |
Engineered antibodies and immunoconjugates
|
|
WO2006135371A1
(en)
|
2005-06-09 |
2006-12-21 |
Kosan Biosciences Incorporated |
Conjugates with reduced adverse systemic effects
|
|
BRPI0611567A2
(pt)
*
|
2005-06-14 |
2016-11-16 |
Gilead Sciences Inc |
composto e/ou sais farmaceuticamente aceitáveis dos mesmos, processo para síntese dos compostos, e formulação aerossol, e, uso de pelo menos uma pró-droga mútua de fenilfosfato
|
|
WO2007056181A2
(en)
|
2005-11-02 |
2007-05-18 |
Sicor, Inc. |
Process for the preparation of ciclesonide
|
|
PT1977252E
(pt)
|
2005-12-22 |
2013-01-28 |
Baxter Int |
Teste de activação de monócitos melhorado mais capaz de detectar contaminantes pirogénicos sem serem endotoxinas em produtos médicos
|
|
US7750116B1
(en)
|
2006-02-18 |
2010-07-06 |
Seattle Genetics, Inc. |
Antibody drug conjugate metabolites
|
|
WO2008127347A1
(en)
|
2006-07-21 |
2008-10-23 |
Diadexus, Inc. |
Pro115 antibody compositions and methods of use
|
|
EP2118120B1
(en)
|
2007-02-05 |
2016-10-05 |
Nicox S.A. |
Nitric oxide releasing steroids
|
|
WO2008122039A2
(en)
|
2007-04-02 |
2008-10-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selenocysteine mediated hybrid antibody molecules
|
|
EP2167963B1
(en)
|
2007-05-23 |
2019-04-17 |
Ventana Medical Systems, Inc. |
Polymeric carriers for immunohistochemistry and in situ hybridization
|
|
EP3569251A1
(en)
|
2007-06-25 |
2019-11-20 |
Endocyte, Inc. |
Conjugates containing hydrophilic spacer linkers
|
|
US20100226987A1
(en)
|
2007-06-28 |
2010-09-09 |
Capsutech Ltd. |
Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers
|
|
CN101397328A
(zh)
|
2007-09-27 |
2009-04-01 |
天津药业研究院有限公司 |
一氧化氮供体型糖皮质激素
|
|
EP2214646B1
(en)
|
2007-10-05 |
2021-06-23 |
Wayne State University |
Dendrimers for sustained release of compounds
|
|
CA2710149A1
(en)
*
|
2007-12-21 |
2009-07-09 |
John C. Anthes |
C20-c21 substituted glucocorticoid receptor agonists
|
|
MX2010007024A
(es)
|
2007-12-21 |
2010-09-30 |
Schering Corp |
Tioéteres c-21 como agonista del receptor de glucocorticoides.
|
|
UA108598C2
(xx)
|
2008-04-30 |
2015-05-25 |
|
Високоефективні кон'югати та гідрофільні зшиваючі агенти (лінкери)
|
|
EP2294077A1
(en)
|
2008-06-10 |
2011-03-16 |
Gilead Sciences, Inc. |
Corticosteroid linked beta-agonist compounds for use in therapy
|
|
AU2009275358C1
(en)
|
2008-07-21 |
2015-09-24 |
Polytherics Limited |
Novel reagents and method for conjugating biological molecules
|
|
US9034325B2
(en)
|
2008-07-22 |
2015-05-19 |
Ablynx N.V. |
Amino acid sequences directed against multitarget scavenger receptors and polypeptides
|
|
CN102348714B
(zh)
|
2009-03-09 |
2015-01-07 |
三笠制药株式会社 |
甾族化合物
|
|
WO2010126953A1
(en)
|
2009-04-29 |
2010-11-04 |
Gilead Sciences, Inc. |
Corticosteroid linked beta-agonist compounds for use in therapy
|
|
WO2010132743A1
(en)
|
2009-05-15 |
2010-11-18 |
Gilead Sciences, Inc. |
Corticosteroid beta-agonist compounds for use in therapy
|
|
CA2770617C
(en)
|
2009-08-10 |
2018-02-20 |
Mark Smith |
Reversible covalent linkage of functional molecules
|
|
WO2011020107A2
(en)
|
2009-08-14 |
2011-02-17 |
Georgetown University |
Compositions and methods for detection and treatment of breast cancer
|
|
GB0917044D0
(en)
|
2009-09-29 |
2009-11-18 |
Cytoguide As |
Agents, uses and methods
|
|
GB0917054D0
(en)
|
2009-09-29 |
2009-11-11 |
Cytoguide As |
Agents, uses and methods
|
|
WO2011081937A1
(en)
|
2009-12-15 |
2011-07-07 |
Gilead Sciences, Inc. |
Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy
|
|
WO2011090940A1
(en)
|
2010-01-19 |
2011-07-28 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
|
CN102844050B
(zh)
|
2010-02-19 |
2019-02-05 |
康奈尔大学 |
自身免疫性脱髓鞘疾病及其它自身免疫疾病或炎性疾病的治疗方法
|
|
NZ602241A
(en)
|
2010-04-15 |
2015-03-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
US20130244905A1
(en)
|
2010-07-06 |
2013-09-19 |
Ed Grabczyk |
Reporter for RNA Polymerase II Termination
|
|
BR112013001634A2
(pt)
|
2010-07-23 |
2016-05-24 |
Takeda Pharmaceutical |
composto ou sal, medicamento, métodos para a profilaxia ou tratamento da arteriosclerose, da diabete ou obesidade em um mamífero, e, uso do composto ou sal
|
|
JP6146913B2
(ja)
|
2010-08-02 |
2017-06-14 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
Ｖｌドメインを含む結合タンパク質を作製するマウス
|
|
UA109150C2
(xx)
|
2010-09-01 |
2015-07-27 |
|
Аміди n-(тетразол-5-іл)- або n-(триазол-5-іл)арилкарбонової кислоти та їх застосування як гербіцидів
|
|
JP5828902B2
(ja)
|
2010-10-29 |
2015-12-09 |
イミュノジェン， インコーポレイテッド |
非拮抗性ｅｇｆｒ結合分子およびその免疫複合体
|
|
US20120302505A1
(en)
|
2011-04-21 |
2012-11-29 |
Fetzer Oliver S |
Cyclodextrin-based polymers for therapeutic delivery
|
|
SG195183A1
(en)
|
2011-05-27 |
2013-12-30 |
Ambrx Inc |
Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
|
|
US8815226B2
(en)
|
2011-06-10 |
2014-08-26 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
CN103997893B
(zh)
|
2011-10-14 |
2019-04-12 |
西雅图基因公司 |
吡咯并苯并二氮杂卓和靶向结合物
|
|
BR112014009070B1
(pt)
|
2011-10-14 |
2021-11-23 |
Medimmune Limited |
Método de síntese e intermediários úteis na preparação de pirrolobenzo-diazepinas
|
|
BR112014008888A2
(pt)
|
2011-10-14 |
2017-04-18 |
Seattle Genetics Inc |
pirrolobenzodiazepinas
|
|
CN103987384A
(zh)
|
2011-10-14 |
2014-08-13 |
西雅图基因公司 |
吡咯并苯并二氮杂卓和靶向结合物
|
|
WO2013068874A1
(en)
|
2011-11-11 |
2013-05-16 |
Pfizer Inc. |
Antibody-drug conjugates
|
|
US20130224228A1
(en)
|
2011-12-05 |
2013-08-29 |
Igenica, Inc. |
Antibody-Drug Conjugates and Related Compounds, Compositions, and Methods
|
|
GB201122325D0
(en)
|
2011-12-23 |
2012-02-01 |
Cytoguide As |
Novel formulations
|
|
KR102283200B1
(ko)
|
2012-03-14 |
2021-07-29 |
리제너론 파마슈티칼스 인코포레이티드 |
다중특이성 항원-결합 분자 및 그것의 용도
|
|
US20150152187A1
(en)
|
2012-06-14 |
2015-06-04 |
Ambrx, Inc. |
Anti-PSMA Antibodies Conjugated to Nuclear Receptor Ligand Polypeptides
|
|
MX363462B
(es)
|
2012-10-11 |
2019-03-25 |
Ascendis Pharma As |
Diagnostico, prevencion y tratamiento de enfermedades de la articulacion.
|
|
MX2015004757A
(es)
|
2012-10-16 |
2015-07-17 |
Endocyte Inc |
Conjugados de suministro de farmacos que contienen aminoacidos no naturales y metodo para usarlos.
|
|
RS56953B1
(sr)
|
2012-10-23 |
2018-05-31 |
Synaffix Bv |
Modifikovano antitelo, konjugat antitela i postupak za njihovu pripremu
|
|
WO2014065575A1
(ko)
|
2012-10-25 |
2014-05-01 |
주식회사유한양행 |
4,5-다이하이드로-1h-피라졸 유도체 또는 그의 염 및 이를 포함하는 약학 조성물
|
|
WO2014105810A1
(en)
|
2012-12-24 |
2014-07-03 |
Abbvie Inc. |
Prolactin receptor binding proteins and uses thereof
|
|
KR102274714B1
(ko)
|
2013-03-13 |
2021-07-09 |
씨젠 인크. |
사이클로덱스트린 및 항체-약물 포합체 제형
|
|
EP2988786A4
(en)
*
|
2013-04-22 |
2016-12-21 |
Avelas Biosciences Inc |
COMPOSITIONS FOR SELECTIVE DRUG ADMINISTRATION AND METHOD OF USE
|
|
ES2759503T3
(es)
|
2013-05-02 |
2020-05-11 |
Glykos Finland Oy |
Conjugados de una glicoproteína o un glicano con una carga útil tóxica
|
|
US11229711B2
(en)
|
2013-06-06 |
2022-01-25 |
Magenta Therapeutics, Inc. |
Linkers for antibody-drug conjugates and related compounds, compositions, and methods of use
|
|
EP3010548A1
(en)
|
2013-06-21 |
2016-04-27 |
Innate Pharma |
Enzymatic conjugation of polypeptides
|
|
EP3020417A4
(en)
|
2013-07-10 |
2017-01-18 |
Seikagaku Corporation |
Pharmaceutical composition for respiratory administration
|
|
TWI641620B
(zh)
|
2013-08-21 |
2018-11-21 |
再生元醫藥公司 |
抗－ｐｒｌｒ抗體及其用途
|
|
KR102356814B1
(ko)
|
2013-10-15 |
2022-01-28 |
씨젠 인크. |
개선된 리간드-약물 컨쥬게이트 약물동력학을 위한 peg화된 약물-링커
|
|
GB201320091D0
(en)
|
2013-11-14 |
2014-01-01 |
Univ Manchester |
Selective glucocorticoid receptor ligands
|
|
CN103694375B
(zh)
|
2013-12-13 |
2016-10-05 |
北京大学 |
一种三萜-环糊精共价化合物及其制备方法和用途
|
|
WO2015110609A1
(en)
|
2014-01-24 |
2015-07-30 |
Centre National De La Recherche Scientifique |
Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating e. coli induced inflammatory bowel diseases such as crohn's disease
|
|
EP3125943A4
(en)
*
|
2014-04-04 |
2017-12-06 |
Merck Sharp & Dohme Corp. |
Phosphate based linkers for intracellular delivery of drug conjugates
|
|
TWI874264B
(zh)
|
2014-04-10 |
2025-02-21 |
日商第一三共股份有限公司 |
抗her3抗體-藥物結合物之用途
|
|
US20170189549A1
(en)
|
2014-06-13 |
2017-07-06 |
Glykos Finland Oy |
Payload-Polymer-Protein Conjugates
|
|
HK1243931A1
(zh)
|
2014-12-03 |
2018-07-27 |
F. Hoffmann-La Roche Ag |
抗金黄色葡萄球菌抗体利福霉素缀合物及其用途
|
|
JP6751393B2
(ja)
|
2014-12-03 |
2020-09-02 |
ジェネンテック， インコーポレイテッド |
抗ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ抗体リファマイシン抱合体及びその使用
|
|
SG10201911585XA
(en)
|
2014-12-09 |
2020-01-30 |
Abbvie Inc |
Bcl xl inhibitory compounds having low cell permeability and antibody drug conjugates including the same
|
|
BR112017012342A2
(pt)
|
2014-12-09 |
2018-02-27 |
Abbvie Inc |
compostos inibitórios de bcl-xl e conjugados de anticorpo-fármaco incluindo os mesmos
|
|
EP3250211B1
(en)
|
2015-01-30 |
2021-12-22 |
Coral Drugs Pvt. Ltd. |
Novel process for preparation of glucocorticoid steroids
|
|
WO2016127081A1
(en)
|
2015-02-06 |
2016-08-11 |
Sorrento Therapeutics, Inc. |
Antibody drug conjugates
|
|
EP3722318A1
(en)
|
2015-07-06 |
2020-10-14 |
Regeneron Pharmaceuticals, Inc. |
Multispecific antigen-binding molecules and uses thereof
|
|
WO2017006279A1
(en)
|
2015-07-08 |
2017-01-12 |
Aten Porus Lifesciences |
Cyclodextrin-polymer complexes and compostions and methods of making and using the same
|
|
JP6823067B2
(ja)
|
2015-09-10 |
2021-01-27 |
タンボ・インコーポレイテッド |
生体直交型組成物
|
|
EP3359194A4
(en)
|
2015-10-06 |
2019-04-24 |
Merck Sharp & Dohme Corp. |
ANTIBODY-ACTIVE CONJUGATE FOR ANTI-INFLAMMATORY APPLICATIONS
|
|
WO2017132103A2
(en)
|
2016-01-29 |
2017-08-03 |
Merck Sharp & Dohme Corp. |
Phosphonate linkers and their use to facilitate cellular retention of compounds
|
|
US11786603B2
(en)
|
2016-02-26 |
2023-10-17 |
Regeneron Pharmaceuticals, Inc. |
Optimized transglutaminase site-specific antibody conjugation
|
|
SG11201807827VA
(en)
|
2016-03-25 |
2018-10-30 |
Seattle Genetics Inc |
Process for the preparation of pegylated drug-linkers and intermediates thereof
|
|
GB201608936D0
(en)
|
2016-05-20 |
2016-07-06 |
Polytherics Ltd |
Novel conjugates and novel conjugating reagents
|
|
PT3464318T
(pt)
|
2016-06-02 |
2021-07-02 |
Abbvie Inc |
Agonista do receptor de glucocorticóide e imunoconjugados dos mesmos
|
|
WO2017214458A2
(en)
|
2016-06-08 |
2017-12-14 |
Abbvie Inc. |
Anti-cd98 antibodies and antibody drug conjugates
|
|
CN110088138B
(zh)
|
2016-09-23 |
2023-08-25 |
瑞泽恩制药公司 |
抗steap2抗体、抗体药物偶联物和结合steap2和cd3的双特异性抗原结合分子以及其用途
|
|
SG10202104259RA
(en)
|
2016-11-08 |
2021-06-29 |
Regeneron Pharma |
Steroids and protein-conjugates thereof
|
|
EP3589328A1
(en)
|
2017-02-28 |
2020-01-08 |
Immunogen, Inc. |
Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof
|
|
JP7728636B2
(ja)
|
2017-05-18 |
2025-08-25 |
レゲネロン ファーマシューティカルス，インコーポレーテッド |
ビス－オクタヒドロフェナントレンカルボキサミド及びそのタンパク質コンジュゲート
|
|
WO2018213077A1
(en)
|
2017-05-18 |
2018-11-22 |
Regeneron Pharmaceuticals, Inc. |
Cyclodextrin protein drug conjugates
|
|
EP3630189A4
(en)
|
2017-05-24 |
2021-06-23 |
The Board of Regents of The University of Texas System |
LINKER FOR ANTIBODY MEDICINAL CONJUGATES
|
|
WO2019034176A1
(zh)
|
2017-08-18 |
2019-02-21 |
四川百利药业有限责任公司 |
一种喜树碱-抗体偶联物
|
|
CN108853514B
(zh)
|
2017-08-18 |
2022-07-22 |
四川百利药业有限责任公司 |
具有两种不同药物的抗体药物偶联物
|
|
IL313068A
(en)
|
2017-11-07 |
2024-07-01 |
Regeneron Pharma |
Hydrophilic linkers for antibody drug conjugates
|
|
PH12020550779A1
(en)
|
2017-12-01 |
2021-04-19 |
Abbvie Inc |
Glucocorticoid receptor agonist and immunoconjugates thereof
|
|
MA50259A1
(fr)
|
2018-01-08 |
2021-07-29 |
Regeneron Pharma |
Stéroïdes et leurs conjugués-anticorps
|
|
SG11202009527PA
(en)
|
2018-04-06 |
2020-10-29 |
Seattle Genetics Inc |
Camptothecin peptide conjugates
|
|
KR20210008008A
(ko)
|
2018-05-09 |
2021-01-20 |
리제너론 파마슈티칼스 인코포레이티드 |
항-msr1 항체 및 이의 사용 방법
|
|
WO2020106780A1
(en)
|
2018-11-20 |
2020-05-28 |
Regeneron Pharmaceuticals, Inc. |
Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as lxr agonists
|
|
SG11202106658XA
(en)
|
2018-12-21 |
2021-07-29 |
Regeneron Pharma |
Rifamycin analogs and antibody-drug conjugates thereof
|
|
CN113905767A
(zh)
|
2019-01-08 |
2022-01-07 |
里珍纳龙药品有限公司 |
无痕连接体及其蛋白质偶联物
|
|
US20230119539A1
(en)
|
2019-01-08 |
2023-04-20 |
Regeneron Pharmaceuticals, Inc. |
Traceless linkers and protein-conjugates thereof
|
